| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,019 |
4,399 |
$2.73M |
| S9484 |
Crisis intervention mental health services, per hour |
5,149 |
1,718 |
$2.40M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,399 |
3,888 |
$2.07M |
| H2021 |
Community-based wrap-around services, per 15 minutes |
1,933 |
1,092 |
$1.27M |
| 99215 |
Prolong outpt/office vis |
2,321 |
1,843 |
$1.10M |
| H2011 |
Crisis intervention service, per 15 minutes |
2,314 |
659 |
$918K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,251 |
440 |
$687K |
| H2015 |
Comprehensive community support services, per 15 minutes |
1,640 |
266 |
$661K |
| 80306 |
|
966 |
496 |
$551K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
677 |
118 |
$538K |
| T1016 |
Case management, each 15 minutes |
678 |
280 |
$365K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
586 |
516 |
$319K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
433 |
400 |
$241K |
| 90832 |
Psychotherapy, 30 minutes with patient |
223 |
142 |
$177K |
| 80053 |
Comprehensive metabolic panel |
567 |
519 |
$169K |
| 99441 |
|
251 |
152 |
$162K |
| D0220 |
Intraoral - periapical first radiographic image |
616 |
527 |
$138K |
| D0140 |
Limited oral evaluation - problem focused |
440 |
382 |
$127K |
| D1110 |
Prophylaxis - adult |
792 |
703 |
$98K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
170 |
129 |
$77K |
| 99408 |
|
113 |
96 |
$69K |
| 80305 |
|
87 |
74 |
$68K |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
120 |
90 |
$61K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
138 |
107 |
$51K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
48 |
47 |
$45K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
359 |
328 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
53 |
51 |
$26K |
| H0046 |
Mental health services, not otherwise specified |
168 |
153 |
$25K |
| H0007 |
Alcohol and/or drug services; crisis intervention (outpatient) |
24 |
12 |
$23K |
| 99442 |
|
33 |
28 |
$23K |
| 90834 |
Psychotherapy, 45 minutes with patient |
17 |
13 |
$16K |
| 99443 |
|
43 |
32 |
$16K |
| D7140 |
Extraction, erupted tooth or exposed root |
67 |
37 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
229 |
219 |
$11K |
| H0001 |
Alcohol and/or drug assessment |
12 |
12 |
$9K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
26 |
24 |
$8K |
| 0011A |
|
55 |
44 |
$7K |
| 96127 |
|
13 |
13 |
$7K |
| D0120 |
Periodic oral evaluation - established patient |
210 |
168 |
$6K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
24 |
24 |
$3K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
15 |
12 |
$3K |
| D8670 |
Periodic orthodontic treatment visit |
132 |
127 |
$3K |
| D0274 |
Bitewings - four radiographic images |
47 |
36 |
$2K |
| D1208 |
Topical application of fluoride, excluding varnish |
42 |
40 |
$2K |
| 0012A |
|
65 |
53 |
$808.00 |
| 82652 |
|
14 |
13 |
$0.00 |
| 80061 |
Lipid panel |
133 |
125 |
$0.00 |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
222 |
50 |
$0.00 |
| 91300 |
|
18 |
16 |
$0.00 |
| 84439 |
|
27 |
27 |
$0.00 |
| 0002A |
|
24 |
18 |
$0.00 |
| D9999 |
Unspecified adjunctive procedure, by report |
4,301 |
3,256 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
97 |
80 |
$0.00 |
| 82607 |
|
25 |
25 |
$0.00 |
| D9310 |
|
24 |
24 |
$0.00 |
| 91301 |
|
128 |
102 |
$0.00 |
| 0031A |
|
16 |
14 |
$0.00 |
| 91303 |
|
16 |
14 |
$0.00 |
| 91305 |
|
17 |
15 |
$0.00 |
| D0007 |
|
12 |
12 |
$0.00 |
| 86803 |
|
14 |
14 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
23 |
22 |
$0.00 |